Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × Physical Therapy Modalities × 1 year × Clear all

Sponsor

Conditions

Neoplasms 4 Motor Activity 3 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Urologic Neoplasms 1 Testicular Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Penile Neoplasms 1 Pain 1 Neuromuscular Diseases 1 Neoplasm Metastasis 1 Myotonic Dystrophy 1 Myositis, Inclusion Body 1 Muscular Dystrophy, Facioscapulohumeral 1 Muscular Dystrophies, Limb-Girdle 1 Muscular Atrophy, Spinal 1 Multiple Myeloma 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Low Anterior Resection Syndrome 1 Lambert-Eaton Myasthenic Syndrome 1 Kidney Neoplasms 1 Hereditary Sensory and Motor Neuropathy 1 Hematologic Neoplasms 1 Guillain-Barre Syndrome 1 Glycogen Storage Disease Type II 1 Glioma 1

Interventions

Paclitaxel 12 Carboplatin 8 pembrolizumab 7 Bevacizumab 7 liposomal doxorubicin 5 Nivolumab 5 mirvetuximab soravtansine 4 Topotecan 4 ribociclib 3 olaparib 3 Fulvestrant 3 Drug Therapy 3 rucaparib 2 pegfilgrastim 2 palbociclib 2 oregovomab 2 niraparib 2 fludarabine phosphate 2 fludarabine 2 Irinotecan 2 Hyperthermic Intraperitoneal Chemotherapy 2 Gemcitabine 2 Cyclophosphamide 2 Blood Specimen Collection 2 1-dodecylpyridoxal 2 trastuzumab deruxtecan 1 spartalizumab 1 sargramostim 1 sacituzumab govitecan 1 isoquercitrin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡